Myriad Genetics, Inc. (MYGN)
4.325
+0.10
(+2.25%)
USD |
NASDAQ |
Sep 30, 16:00
4.325
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics EPS Diluted (TTM) : -1.199 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.199 |
| March 31, 2026 | -4.316 |
| December 31, 2025 | -3.953 |
| September 30, 2025 | -4.335 |
| June 30, 2025 | -4.284 |
| March 31, 2025 | -1.116 |
| December 31, 2024 | -1.404 |
| September 30, 2024 | -1.300 |
| June 30, 2024 | -1.805 |
| March 31, 2024 | -2.821 |
| December 31, 2023 | -3.205 |
| September 30, 2023 | -3.361 |
| June 30, 2023 | -3.048 |
| March 31, 2023 | -1.802 |
| December 31, 2022 | -1.385 |
| September 30, 2022 | -0.9613 |
| June 30, 2022 | -0.2246 |
| March 31, 2022 | -0.1101 |
| December 31, 2021 | -0.3739 |
| September 30, 2021 | -1.021 |
| June 30, 2021 | -2.870 |
| March 31, 2021 | -2.920 |
| June 30, 2020 | -2.68 |
| March 31, 2020 | -1.995 |
| December 31, 2019 | -0.3562 |
| Date | Value |
|---|---|
| September 30, 2019 | -0.2106 |
| June 30, 2019 | 0.0593 |
| March 31, 2019 | 0.3154 |
| December 31, 2018 | 0.349 |
| September 30, 2018 | 0.7448 |
| June 30, 2018 | 1.874 |
| March 31, 2018 | 1.865 |
| December 31, 2017 | 1.799 |
| September 30, 2017 | 1.459 |
| June 30, 2017 | 0.32 |
| March 31, 2017 | 0.45 |
| December 31, 2016 | 0.86 |
| September 30, 2016 | 1.18 |
| June 30, 2016 | 1.57 |
| March 31, 2016 | 1.51 |
| December 31, 2015 | 1.33 |
| September 30, 2015 | 1.24 |
| June 30, 2015 | 1.08 |
| March 31, 2015 | 1.25 |
| December 31, 2014 | 1.44 |
| September 30, 2014 | 1.78 |
| June 30, 2014 | 2.25 |
| March 31, 2014 | 2.35 |
| December 31, 2013 | 2.33 |
| September 30, 2013 | 2.09 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Natera, Inc. | -1.368 |
| Sera Prognostics, Inc. | -0.6636 |
| BioRestorative Therapies, Inc. | -22.40 |
| CareDx, Inc. | 2.075 |
| Exagen, Inc. | -0.8057 |